Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Moodys
McKesson
Mallinckrodt
Merck

Last Updated: April 2, 2020

DrugPatentWatch Database Preview

Robins Ah Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ROBINS AH, and what generic and branded alternatives to ROBINS AH drugs are available?

ROBINS AH has ten approved drugs.



Summary for Robins Ah
US Patents:0
Tradenames:10
Ingredients:7
NDAs:10

Drugs and US Patents for Robins Ah

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Robins Ah REGLAN metoclopramide hydrochloride SOLUTION;ORAL 018821-001 Mar 25, 1983 DISCN Yes No   Start Trial   Start Trial
Robins Ah PHENAPHEN W/ CODEINE NO. 2 acetaminophen; codeine phosphate CAPSULE;ORAL 084444-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Robins Ah ROBIMYCIN erythromycin TABLET, DELAYED RELEASE;ORAL 061633-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Robins Ah TENATHAN bethanidine sulfate TABLET;ORAL 017675-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Robins Ah DIMETANE-DX brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride SYRUP;ORAL 019279-001 Aug 24, 1984 DISCN Yes No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Robins Ah

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Robins Ah TENATHAN bethanidine sulfate TABLET;ORAL 017675-001 Approved Prior to Jan 1, 1982 3,495,013   Start Trial
Robins Ah TENATHAN bethanidine sulfate TABLET;ORAL 017675-002 Approved Prior to Jan 1, 1982 3,495,013   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for ROBINS AH drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 1 mg ➤ Subscribe 2009-08-14
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Colorcon
Moodys
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.